Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024

Date: March 7, 2019
Pages: 195
Price:
US$ 5,650.00
License [?]:
Publisher: MarketsandMarkets
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G7E2D6E3CA8EN
Leaflet:

Download PDF Leaflet

Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024
“Genomics market is projected to grow at a CAGR of 13.5% during the forecast period”

The global genomics market is projected to reach USD 35.7 billion by 2024 from USD 18.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Factors such as the rising government funding and growth in the number of genomics projects, decreasing sequencing costs, growing application areas of genomics, and the entry of new players and start-ups in the genomics field are driving the growth of the genomics market. However, the high cost of genomic equipment is one of the major factors restraining the growth of this market.

“The services segment is projected to grow at the highest CAGR during the forecast period”

Based on product & service, the genomics market is segmented into consumables, systems & software, and services. During the forecast period, the services segment is expected to grow at the highest CAGR majorly due to the increasing awareness of genomics and the reducing cost of DNA sequencing.

“Diagnostic applications to grow at the highest CAGR during the forecast period”

Based on application, the genomics market is segmented into diagnostics, drug discovery and development, personalized medicine, agriculture and animal research, and other applications. During the forecast period, the diagnostic applications segment is projected to grow at the highest CAGR majorly due to the increasing awareness of genomics among patients and the improving efficiency of genomic sequencing in the diagnosis of diseases.

“In the end-user market, the hospitals and clinics segment is estimated to witness the highest growth during the forecast period”

Based on end user, the genomics market is segmented into research centers and academic & government institutes, hospitals and clinics, pharmaceutical and biotechnology companies, and other end users. During the forecast period, the hospitals and clinics segment is estimated to grow at the highest CAGR owing to the growing availability of genetic tests and pharmacogenomics and the rising emphasis on providing personalized medicine in hospitals.

“Growing investments and favorable government initiatives for genomics research to offer growth opportunities in North America during the forecast period”

During the forecast period, the North American market is estimated to witness high growth owing to factors such as the implementation of favorable initiatives by governments in the US and Canada and rising investments in the pharmaceutical, biotechnology, medical, and academic research sectors in these countries.

Breakdown of supply-side primary interviews:
  • By Company Type – Tier I: 55%, Tier II: 25%, and Tier III: 20%
  • By Designation – C-level: 43%, Director-level: 32%, and Others: 25%
  • By Region – North America: 38%, Europe: 23%, Asia Pacific: 29%, and RoW: 10%
QIAGEN (Netherlands), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Agilent Technologies (US), Illumina (US), Pacific Biosciences of California (US), Eurofins Scientific (Germany), BGI (China), GE Healthcare (UK), F. Hoffmann-La Roche (Switzerland), Oxford Nanopore Technologies (UK), and Eppendorf (Germany) are the major players operating in this market.

Research coverage:

This report studies the genomics market based on product and service, application, end user, and region. It also includes an analysis of factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key benefits of buying the report

This report focuses on various levels of analysis—industry trends, the market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the genomics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
  1.3.1 MARKETS COVERED
  1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
  2.2.1 MARKET DATA VALIDATION AND TRIANGULATION
2.3 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 GENOMICS: MARKET OVERVIEW
4.2 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2018
4.3 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2018
4.4 GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 DRIVERS
    5.2.1.1 Rising government funding and growth in the number of genomics projects
    5.2.1.2 Decreasing sequencing costs
    5.2.1.3 Growing application areas of genomics
    5.2.1.4 Entry of new players and start-ups in the genomics market
  5.2.2 RESTRAINTS
    5.2.2.1 High cost of genomic equipment
  5.2.3 OPPORTUNITIES
    5.2.3.1 Use of genomics in specialized/personalized medicine
  5.2.4 CHALLENGES
    5.2.4.1 Dearth of trained professionals
    5.2.4.2 Secure storage of large volumes of sequenced data

6 GENOMICS MARKET, BY PRODUCT AND SERVICE

6.1 INTRODUCTION
6.2 CONSUMABLES
  6.2.1 CONSUMABLES FORMS THE LARGEST SEGMENT OF THE GENOMICS MARKET
6.3 SYSTEMS & SOFTWARE
  6.3.1 WITH GENOME SEQUENCING AVAILABLE AT SUBSTANTIALLY LOWER RATES, THE DEMAND FOR SYSTEMS & SOFTWARE IS EXPECTED TO INCREASE
6.4 SERVICES
  6.4.1 THE SERVICES SEGMENT IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD

7 GENOMICS MARKET, BY TECHNOLOGY

7.1 INTRODUCTION
7.2 PCR
  7.2.1 PCR ALLOWS RESEARCHERS TO PRODUCE MILLIONS OF COPIES OF A SPECIFIC DNA SEQUENCE WITHIN HOURS
7.3 SEQUENCING
  7.3.1 INCREASING APPLICATIONS OF SEQUENCING IN ANIMAL BREEDING, AGRICULTURE, AND HUMAN GENOMICS TO DRIVE MARKET GROWTH
7.4 MICROARRAY
  7.4.1 MICROARRAY TECHNOLOGIES ARE WIDELY USED IN THE FIELD OF GENOMICS DUE TO THEIR LOW COST
7.5 NUCLEIC ACID EXTRACTION AND PURIFICATION
  7.5.1 ADVANCES IN NUCLEIC ACID EXTRACTION AND PURIFICATION TECHNOLOGIES ARE EXPECTED TO SUPPORT THE GROWTH OF THIS MARKET
7.6 OTHER TECHNOLOGIES

8 GENOMICS MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 DIAGNOSTICS
  8.2.1 DIAGNOSTICS FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE GENOMICS MARKET
8.3 DRUG DISCOVERY AND DEVELOPMENT
  8.3.1 GROWING APPLICATION OF GENOMICS IN THE AREA OF DRUG DISCOVERY AND DEVELOPMENT TO PROPEL MARKET GROWTH
8.4 PRECISION MEDICINE
  8.4.1 PRECISION MEDICINE FOCUSES ON IDENTIFYING THE MOST EFFECTIVE MEDICAL TREATMENTS FOR PATIENTS BASED ON THEIR GENETIC, ENVIRONMENTAL, AND LIFESTYLE FACTORS
8.5 AGRICULTURE & ANIMAL RESEARCH
  8.5.1 GENOMICS HELPS IN IMPROVING THE PRODUCTIVITY OF CROPS AND LIVESTOCK
8.6 OTHER APPLICATIONS

9 GENOMICS MARKET, BY END USER

9.1 INTRODUCTION
9.2 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
  9.2.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF GENOMICS SYSTEMS AMONG ACADEMIC & GOVERNMENT INSTITUTES
9.3 HOSPITALS & CLINICS
  9.3.1 INCREASING DEMAND FOR PHARMACOGENOMICS TO DRIVE THE ACCEPTANCE OF NGS IN HOSPITALS
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE THE USE OF GENOMIC SYSTEMS AND SERVICES AMONG PHARMA & BIOTECH COMPANIES
9.5 OTHER END USERS

10 GENOMICS MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
  10.2.1 US
    10.2.1.1 US dominates the North American genomics market due to the increasing research funding and government initiatives for promoting precision medicine and the use of GM crops
  10.2.2 CANADA
    10.2.2.1 Increasing research in the field of genomics to drive market growth
10.3 EUROPE
  10.3.1 UK
    10.3.1.1 UK to register the highest CAGR in the European genomics market during the forecast period
  10.3.2 GERMANY
    10.3.2.1 Availability of funding for life sciences research to boost market growth in Germany
  10.3.3 FRANCE
    10.3.3.1 Increasing government investments in genomics to boost the growth of the French genomics market
  10.3.4 ROE
10.4 ASIA PACIFIC
  10.4.1 CHINA
    10.4.1.1 China is expected to command the largest share of the Asia Pacific market
  10.4.2 INDIA
    10.4.2.1 Emergence of local players is expected to aid the growth of the genomics market in India
  10.4.3 JAPAN
    10.4.3.1 Increasing government focus on cancer research in Japan to increase demand for genomics products
  10.4.4 REST OF ASIA PACIFIC
10.5 REST OF THE WORLD
  10.5.1 MIDDLE EAST AND AFRICA
    10.5.1.1 Increasing adoption of genetic testing in the Middle East and rising HIV & cancer incidence in Africa are driving market growth
  10.5.2 LATIN AMERICA
    10.5.2.1 Government funding and partnerships to boost the adoption of genomics products and services in Latin America

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW
  11.1.1 THERMO FISHER SCIENTIFIC
  11.1.2 ILLUMINA
  11.1.3 QIAGEN
  11.1.4 OTHERS
11.2 COMPETITIVE SCENARIO
  11.2.1 PRODUCT LAUNCHES AND APPROVALS
  11.2.2 EXPANSIONS
  11.2.3 AGREEMENTS AND COLLABORATIONS
  11.2.4 ACQUISITIONS
11.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2018)
  11.3.1 VISIONARY LEADERS
  11.3.2 INNOVATORS
  11.3.3 DYNAMIC DIFFERENTIATORS
  11.3.4 EMERGING COMPANIES
11.4 COMPETITIVE BENCHMARKING
  11.4.1 ANALYSIS OF THE PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE GENOMICS MARKET (25 COMPANIES)
  11.4.2 BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE GENOMICS MARKET (25 COMPANIES)
11.5 COMPETITIVE LEADERSHIP MAPPING (START-UP) (2018)
  11.5.1 PROGRESSIVE COMPANIES
  11.5.2 STARTING BLOCKS
  11.5.3 DYNAMIC COMPANIES
  11.5.4 RESPONSIVE COMPANIES

12 COMPANY PROFILES

(Business Overview, Products Offered, Service Offered Recent Developments, MnM View)*

12.1 ILLUMINA, INC.
12.2 THERMO FISHER SCIENTIFIC
12.3 QIAGEN
12.4 EUROFINS SCIENTIFIC
12.5 AGILENT TECHNOLOGIES
12.6 OXFORD NANOPORE TECHNOLOGIES
12.7 F. HOFFMANN-LA ROCHE
12.8 BIO-RAD LABORATORIES
12.9 BGI
12.10 DANAHER CORPORATION
12.11 GE HEALTHCARE
12.12 EPPENDORF

*Business Overview, Products Offered, Service Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 GENOMICS MARKET, BY PRODUCT AND SERVICE, 2017–2024 (USD MILLION)
TABLE 2 GENOMICS MARKET FOR CONSUMABLES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 3 GENOMICS MARKET FOR SYSTEMS/SOFTWARE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 4 GENOMICS MARKET FOR SERVICES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 5 GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 6 GENOMICS MARKET FOR PCR, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 7 GENOMICS MARKET FOR SEQUENCING, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 8 GENOMICS MARKET FOR MICROARRAY, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 9 GENOMICS MARKET FOR NUCLEIC ACID EXTRACTION AND PURIFICATION, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 10 GENOMICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 11 GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 12 GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 13 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 14 GENOMICS MARKET FOR PRECISION MEDICINE, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 15 GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 16 GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 17 GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 18 GENOMICS MARKET FOR RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 19 GENOMICS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 20 GENOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 21 GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 22 GENOMICS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 23 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 24 NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 25 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 26 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 27 NORTH AMERICA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 28 US: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 29 US: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 30 US: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 31 US: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 32 INDICATIVE LIST OF PROJECTS FUNDED BY GAPP IN 2018
TABLE 33 CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 34 CANADA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 35 0CANADA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 36 CANADA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 37 EUROPE: GENOMICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 38 EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 39 EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 40 EUROPE: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 41 EUROPE: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 42 UK: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 43 UK: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 44 UK: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 45 UK: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 46 GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 47 GERMANY: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 48 GERMANY: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 49 GERMANY: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 50 FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 51 FRANCE: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 52 FRANCE : GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 53 FRANCE: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 54 ROE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 55 ROE: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 56 ROE: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 57 ROE: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 58 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 59 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 60 ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 61 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 62 ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 63 CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 64 CHINA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 65 CHINA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 66 CHINA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 67 INDIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 68 INDIA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 69 INDIA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 70 INDIA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 71 JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 72 JAPAN: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 73 JAPAN: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 74 JAPAN: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 75 ROAPAC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 76 ROAPAC: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 77 ROAPAC: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 78 ROAPAC: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 79 ROW: GENOMICS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 80 ROW: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 81 ROW: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 82 ROW: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 83 ROW: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 84 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 85 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 86 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 87 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 88 LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 89 LATIN AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 90 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 91 LATIN AMERICA: GENOMICS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 92 PRODUCT LAUNCHES AND APPROVALS
TABLE 93 EXPANSIONS
TABLE 94 AGREEMENTS AND COLLABORATIONS
TABLE 95 ACQUISITIONS

LIST OF FIGURES

FIGURE 1 GENOMICS MARKET SEGMENTATION
FIGURE 2 GENOMICS MARKET: RESEARCH METHODOLOGY
FIGURE 3 RESEARCH DESIGN
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 GENOMICS MARKET, BY PRODUCT & SERVICE, 2018
FIGURE 9 GENOMICS MARKET, BY TECHNOLOGY, 2018
FIGURE 10 GENOMICS MARKET, BY APPLICATION, 2018
FIGURE 11 GENOMICS MARKET, BY END USER, 2018
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE GENOMICS MARKET
FIGURE 13 RISING GOVERNMENT FUNDING AND GROWTH IN THE NUMBER OF GENOMICS PROJECTS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 14 PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN GENOMICS MARKET IN 2018
FIGURE 15 CONSUMABLES SEGMENT COMMANDED THE LARGEST SHARE OF THE ASIA PACIFIC GENOMICS MARKET IN 2018
FIGURE 16 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 17 CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE GENOMICS MARKET IN 2019
FIGURE 18 PCR SEGMENT WILL CONTINUE TO DOMINATE THE GENOMICS MARKET IN THE FORECAST PERIOD
FIGURE 19 DIAGNOSTIC APPLICATIONS TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD
FIGURE 20 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES TO COMMAND THE LARGEST SHARE OF THE GENOMICS MARKET IN 2019
FIGURE 21 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GENOMICS MARKET DURING THE FORECAST PERIOD
FIGURE 22 NORTH AMERICA: GENOMICS MARKET SNAPSHOT
FIGURE 23 EUROPE: GENOMICS MARKET SNAPSHOT
FIGURE 24 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
FIGURE 25 ROW: GENOMICS MARKET SNAPSHOT
FIGURE 26 GENOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2018
FIGURE 27 COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET
FIGURE 28 COMPETITIVE LEADERSHIP MAPPING: GENOMICS MARKET
FIGURE 29 ILLUMINA, INC.: COMPANY SNAPSHOT (2018)
FIGURE 30 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2017)
FIGURE 31 QIAGEN N.V.: COMPANY SNAPSHOT (2017)
FIGURE 32 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017)
FIGURE 33 AGILENT TECHNOLOGIES : COMPANY SNAPSHOT (2017)
FIGURE 34 ROCHE HOLDING AG: COMPANY SNAPSHOT (2017)
FIGURE 35 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2017)
FIGURE 36 DANAHER CORPORATION: COMPANY SNAPSHOT (2017)
FIGURE 37 GENERAL ELECTRICAL COMPANY: COMPANY SNAPSHOT (2017)
FIGURE 38 EPPENDORF AG: COMPANY SNAPSHOT (2017)
Skip to top


Ask Your Question

Genomics Market by Product and Service (Systems & Software, Consumables, Services), Technology (Sequencing, Microarray, PCR), Application (Diagnostic Application, and Precision Medicine), End User (Research Institute) - Global Forecast to 2024
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: